Literature DB >> 11561025

Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer's disease.

A T Du1, N Schuff, D Amend, M P Laakso, Y Y Hsu, W J Jagust, K Yaffe, J H Kramer, B Reed, D Norman, H C Chui, M W Weiner.   

Abstract

OBJECTIVES: To explore volume changes of the entorhinal cortex (ERC) and hippocampus in mild cognitive impairment (MCI) and Alzheimer's disease (AD) compared with normal cognition (NC); to determine the powers of the ERC and the hippocampus for discrimination between these groups.
METHODS: This study included 40 subjects with NC, 36 patients with MCI, and 29 patients with AD. Volumes of the ERC and hippocampus were manually measured based on coronal T1 weighted MR images. Global cerebral changes were assessed using semiautomatic image segmentation.
RESULTS: Both ERC and hippocampal volumes were reduced in MCI (ERC 13%, hippocampus 11%, p<0.05) and AD (ERC 39%, hippocampus 27%, p<0.01) compared with NC. Furthermore, AD showed greater volume losses in the ERC than in the hippocampus (p<0.01). In addition, AD and MCI also had cortical grey matter loss (p< 0.01) and ventricular enlargement (p<0.01) when compared with NC. There was a significant correlation between ERC and hippocampal volumes in MCI and AD (both p<0.001), but not in NC. Using ERC and hippocampus together improved discrimination between AD and CN but did not improve discrimination between MCI and NC. The ERC was better than the hippocampus for distinguishing MCI from AD. In addition, loss of cortical grey matter significantly contributed to the hippocampus for discriminating MCI and AD from NC.
CONCLUSIONS: Volume reductions in the ERC and hippocampus may be early signs of AD pathology that can be measured using MRI.

Entities:  

Mesh:

Year:  2001        PMID: 11561025      PMCID: PMC1763497          DOI: 10.1136/jnnp.71.4.441

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  41 in total

1.  Anatomic basis of amygdaloid and hippocampal volume measurement by magnetic resonance imaging.

Authors:  C Watson; F Andermann; P Gloor; M Jones-Gotman; T Peters; A Evans; A Olivier; D Melanson; G Leroux
Journal:  Neurology       Date:  1992-09       Impact factor: 9.910

2.  Hippocampal volume losses in minimally impaired elderly.

Authors:  A Convit; M J de Leon; C Tarshish; S De Santi; A Kluger; H Rusinek; A E George
Journal:  Lancet       Date:  1995-01-28       Impact factor: 79.321

3.  Usefulness of MRI measures of entorhinal cortex versus hippocampus in AD.

Authors:  Y Xu; C R Jack; P C O'Brien; E Kokmen; G E Smith; R J Ivnik; B F Boeve; R G Tangalos; R C Petersen
Journal:  Neurology       Date:  2000-05-09       Impact factor: 9.910

4.  Quantitative changes in mesial temporal volume, regional cerebral blood flow, and cognition in Alzheimer's disease.

Authors:  G D Pearlson; G J Harris; R E Powers; P E Barta; E E Camargo; G A Chase; J T Noga; L E Tune
Journal:  Arch Gen Psychiatry       Date:  1992-05

5.  APOE-epsilon4 is associated with less frontal and more medial temporal lobe atrophy in AD.

Authors:  C Geroldi; M Pihlajamäki; M P Laakso; C DeCarli; A Beltramello; A Bianchetti; H Soininen; M Trabucchi; G B Frisoni
Journal:  Neurology       Date:  1999-11-10       Impact factor: 9.910

6.  Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease.

Authors:  R J Killiany; T Gomez-Isla; M Moss; R Kikinis; T Sandor; F Jolesz; R Tanzi; K Jones; B T Hyman; M S Albert
Journal:  Ann Neurol       Date:  2000-04       Impact factor: 10.422

Review 7.  Staging of Alzheimer-related cortical destruction.

Authors:  H Braak; E Braak; J Bohl
Journal:  Eur Neurol       Date:  1993       Impact factor: 1.710

8.  Quantification of magnetic resonance scans for hippocampal and parahippocampal atrophy in Alzheimer's disease.

Authors:  J P Kesslak; O Nalcioglu; C W Cotman
Journal:  Neurology       Date:  1991-01       Impact factor: 9.910

9.  MR-based hippocampal volumetry in the diagnosis of Alzheimer's disease.

Authors:  C R Jack; R C Petersen; P C O'Brien; E G Tangalos
Journal:  Neurology       Date:  1992-01       Impact factor: 9.910

10.  Volumes of hippocampus, amygdala and frontal lobes in the MRI-based diagnosis of early Alzheimer's disease: correlation with memory functions.

Authors:  M P Laakso; H Soininen; K Partanen; E L Helkala; P Hartikainen; P Vainio; M Hallikainen; T Hänninen; P J Riekkinen
Journal:  J Neural Transm Park Dis Dement Sect       Date:  1995
View more
  233 in total

1.  Past glory and future promise: maximizing and improving understanding of atrophy patterns in the diagnosis of degenerative dementias.

Authors:  Bruce L Miller
Journal:  AJNR Am J Neuroradiol       Date:  2002-01       Impact factor: 3.825

Review 2.  Patterns of compensation and vulnerability in normal subjects at risk of Alzheimer's disease.

Authors:  Oscar L Lopez; James T Becker; Lewis H Kuller
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

3.  Event-related functional magnetic resonance imaging changes during relational retrieval in normal aging and amnestic mild cognitive impairment.

Authors:  Kelly S Giovanello; Felipe De Brigard; Jaclyn Hennessey Ford; Daniel I Kaufer; James R Burke; Jeffrey N Browndyke; Kathleen A Welsh-Bohmer
Journal:  J Int Neuropsychol Soc       Date:  2012-05-24       Impact factor: 2.892

4.  Longitudinal changes in cortical thickness associated with normal aging.

Authors:  Madhav Thambisetty; Jing Wan; Aaron Carass; Yang An; Jerry L Prince; Susan M Resnick
Journal:  Neuroimage       Date:  2010-05-02       Impact factor: 6.556

5.  Longitudinal MRI atrophy biomarkers: relationship to conversion in the ADNI cohort.

Authors:  Shannon L Risacher; Li Shen; John D West; Sungeun Kim; Brenna C McDonald; Laurel A Beckett; Danielle J Harvey; Clifford R Jack; Michael W Weiner; Andrew J Saykin
Journal:  Neurobiol Aging       Date:  2010-08       Impact factor: 4.673

6.  Differentiating Between Healthy Control Participants and Those with Mild Cognitive Impairment Using Volumetric MRI Data.

Authors:  Renée DeVivo; Lauren Zajac; Asim Mian; Anna Cervantes-Arslanian; Eric Steinberg; Michael L Alosco; Jesse Mez; Robert Stern; Ronald Killany
Journal:  J Int Neuropsychol Soc       Date:  2019-05-27       Impact factor: 2.892

7.  Voxel Level Survival Analysis of Grey Matter Volume and Incident Mild Cognitive Impairment or Alzheimer's Disease.

Authors:  Lubov E Zeifman; William F Eddy; Oscar L Lopez; Lewis H Kuller; Cyrus Raji; Paul M Thompson; James T Becker
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

8.  Automated 3D mapping of hippocampal atrophy and its clinical correlates in 400 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls.

Authors:  Jonathan H Morra; Zhuowen Tu; Liana G Apostolova; Amity E Green; Christina Avedissian; Sarah K Madsen; Neelroop Parikshak; Xue Hua; Arthur W Toga; Clifford R Jack; Norbert Schuff; Michael W Weiner; Paul M Thompson
Journal:  Hum Brain Mapp       Date:  2009-09       Impact factor: 5.038

9.  An APOE-independent cis-eSNP on chromosome 19q13.32 influences tau levels and late-onset Alzheimer's disease risk.

Authors:  Shuquan Rao; Mahdi Ghani; Zhiyun Guo; Yuetiva Deming; Kesheng Wang; Rebecca Sims; Canquan Mao; Yao Yao; Carlos Cruchaga; Dietrich A Stephan; Ekaterina Rogaeva
Journal:  Neurobiol Aging       Date:  2018-01-03       Impact factor: 4.673

10.  A Long-Living Bioengineered Neural Tissue Platform to Study Neurodegeneration.

Authors:  Nicolas Rouleau; William L Cantley; Volha Liaudanskaya; Alexander Berk; Chuang Du; William Rusk; Emily Peirent; Cole Koester; Thomas J F Nieland; David L Kaplan
Journal:  Macromol Biosci       Date:  2020-02-17       Impact factor: 4.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.